Frequency and Costs Associated with Targeted Therapy-Related Adverse Events (AES) During First and Second Line of Treatment (LOT) Among Patients with Metastatic Colorectal Cancer (MCRC)
May 1, 2014, 00:00
10.1016/j.jval.2014.03.470
https://www.valueinhealthjournal.com/article/S1098-3015(14)00521-X/fulltext
Title :
Frequency and Costs Associated with Targeted Therapy-Related Adverse Events (AES) During First and Second Line of Treatment (LOT) Among Patients with Metastatic Colorectal Cancer (MCRC)
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(14)00521-X&doi=10.1016/j.jval.2014.03.470
First page :
A80
Section Title :
Cancer
Open access? :
No
Section Order :
1519